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Abstract
Background: Artificial fluoridation of drinking water to improve dental health has long
been a topic of controversy. Opponents of this public health measure have cited the pos-
sibility of bone cancer induction. The study objective was to examine whether increased
risk of primary bone cancer was associated with living in areas with higher concentra-
tions of fluoride in drinking water.
Methods: Case data on osteosarcoma and Ewing sarcoma, diagnosed at ages 0–49 years
in Great Britain (GB) (defined here as England, Scotland and Wales) during the period
1980–2005, were obtained from population-based cancer registries. Data on fluoride lev-
els in drinking water in England and Wales were accessed through regional water com-
panies and the Drinking Water Inspectorate. Scottish Water provided data for Scotland.
Negative binomial regression was used to examine the relationship between incidence
rates and level of fluoride in drinking water at small area level.
Results: The study analysed 2566 osteosarcoma and 1650 Ewing sarcoma cases. There
was no evidence of an association between osteosarcoma risk and fluoride in drinking
water [relative risk (RR) per one part per million increase in the level of fluoride¼1001;
90% confidence interval (CI) 0871, 1151] and similarly there was no association for
Ewing sarcoma (RR¼0929; 90% CI 0773, 1115).
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Conclusions: The findings from this study provide no evidence that higher levels of fluor-
ide (whether natural or artificial) in drinking water in GB lead to greater risk of either
osteosarcoma or Ewing sarcoma.
Key words: Osteosarcoma, Ewing sarcoma, bone cancer, children, young people, artificial fluoridation, fluoride,
drinking water, Great Britain, small area analysis
Introduction
Primary bone cancer is the third most common cancer in
10–24-year-olds, mainly comprising osteosarcoma and
Ewing sarcoma (ES).1 The aetiology is unclear, but both
genetic and environmental factors are likely to be
involved.1,2
Fluoride occurs naturally in drinking water at varying
concentrations. Water is a primary dietary fluoride source.
Populations supplied with high levels of naturally occur-
ring fluoride in drinking water have low levels of dental
caries.3 The optimum range for dental health benefit is
07–12 parts per million (ppm). Concentrations below
03 ppm may provide no benefit.4
The recognition of an association between prevalence of
dental caries and areas of greater socio-economic depriv-
ation led to artificial fluoridation of water supplies in some
countries, including in parts of Great Britain (GB), defined
here as England, Scotland and Wales.5 Pilot schemes estab-
lished in the 1950s included: Kilmarnock (1956–62); part
of Anglesey (1955–92); Andover (1955–58) and Watford
(1956–89).6–8 Artificial fluoridation programmes were
introduced during the 1960s. Currently five water compa-
nies artificially fluoridate some drinking water supplies
under the instruction of health authorities (Figure 1).9
This practice has been controversial and there is specu-
lation that adding fluoride to community water supplies
could result in adverse health outcomes including increased
risk of cancer, particularly osteosarcoma.10 Two system-
atic reviews concluded there was no clear association
between water fluoridation and osteosarcoma incidence or
mortality, but both advised caution in view of heterogen-
eity and other methodological concerns.11,12
The present study used the same case dataset as a previ-
ous demographic analysis that tested whether spatial vari-
ation among osteosarcoma and ES was associated with
population density and area-based deprivation. Area-based
deprivation is an ecological measure used for examining
socio-economic data according to a small geographical
unit. The previous ecological study found higher incidence
of osteosarcoma for females in less deprived areas and of
ES in areas of low population density and high car owner-
ship. The putative association between osteosarcoma and
ES risk and fluoride in drinking water was not analysed.13
The present study objective was to examine whether
osteosarcoma risk was associated with fluoride levels in
drinking water. For comparison, ES was also studied. This
study is the first to analyse fluoride monitoring data as
part of the exposure measurement and the putative associ-
ation with osteosarcoma risk in small geographical areas
across the whole of GB. No distinction was made between
artificial or naturally occurring fluoride in drinking water,
and novel geographical information system (GIS) method-
ologies were utilised to assign fluoride levels at small area
level. The following hypotheses were tested: (i) geograph-
ical heterogeneity of osteosarcoma incidence is modulated
by differences in fluoride levels in drinking water; and
(ii) geographical heterogeneity of ES incidence is not
modulated by differences in fluoride levels.
Key Messages
• There was no evidence of an association between fluoride in drinking water and osteosarcoma or Ewing sarcoma
before or after adjustment for small area level deprivation.
• 33% of artificially fluoridated water supply zones in Great Britain were found to be supplying water that was below
07 parts per million of fluoride, the lower limit of the optimal level for dental health benefit.
• There was no evidence that those who lived in an artificially fluoridated area of Great Britain were at increased risk
of osteosarcoma or Ewing sarcoma.
• There was no evidence that those living in an area of Great Britain with naturally occurring fluoride within the optimal
level for dental health benefit were at increased risk of osteosarcoma or Ewing sarcoma.
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Methods
Study subjects
Data for patients diagnosed with osteosarcoma or ES in
GB during 1980–2005 were analysed. Cases were limited
to ages 0–49 years, as there are few ES cases above these
ages and osteosarcoma over the age of 50 years is usually
associated with Paget’s disease or is secondary to radio-
therapy.2,14 To ensure sufficient case numbers in each cat-
egory at small area level, cases were sub-divided into age
groups 0–14, 15–29 and 30–49 years at diagnosis.
Regulatory and ethical approvals were gained (UK
National Research Ethics Service reference number
09/H0904/5). Case data were accessed from the 10 re-
gional cancer registries in GB. Case data from the National
Registry of Childhood Tumours were extracted and used
to cross-check accuracy of the regional registry cases aged
0–14 years.
Diagnostic groups
Cases were grouped using the International Classification
of Diseases for Oncology, third edition (ICD-O-3).15
Osteosarcoma and ES were specified a priori and the asso-
ciated topography and morphology codes are given
elsewhere.13
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Figure 1. Map of England and Wales illustrating the boundaries of the water companies with artificial fluoridation programmes in place.
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Population data
Denominator data were derived from national decennial
census data.16–21 Analyses over a prolonged time span are
impeded by boundary changes, especially at small area
level.22 Therefore, population counts from previous
censuses and geo-referenced bone cancer registration data
were adjusted to be compatible with 2001 census bounda-
ries.23 The small area units (SAU) used in the analyses were
census wards in England and Wales (0–49-years-old popu-
lation ranges from 297 to 29 300, median¼ 3090), and
postcode sectors in Scotland (0–49-years-old population
ranges from 23 to 15 916, median¼3201).
Similarly, to adjust for deprivation, a time-series of indi-
cators was obtained from each census during the study
period and geographically converted to be compatible with
2001 SAUs. The Townsend index (comprising four compo-
nents: unemployment, non-car ownership, non-home own-
ership and household overcrowding) is commonly used in
health studies.24 To track changes in deprivation for every
SAU at the different time points, each variable was
expressed as a z-score relative to the GB average level over
the study period, then summed and equally weighted to a
single deprivation score.25
Fluoride monitoring data
At the time of the study, 25 companies in GB supplied
water to 2265 statutorily demarcated ‘water supply zones’
(WSZs) with a population supply threshold of 100 000
(Water Regulation Zones in Scotland). Less than 1% of
households have private water supplies.26 Fluoride level in
drinking water is continuously monitored and required to
be less than 15 ppm on a 3–month average basis.27,28
These routine fluoride monitoring data were utilised in this
study and obtained through Scottish Water and a regula-
tory body, the Drinking Water Inspectorate (DWI) for
companies in England and Wales.
Digital boundary data
Digital boundaries for census areas facilitated geo-
referenced data linkage for statistical analysis and were
accessed from UK Borders.29,30 Digital boundaries for
WSZs were accessed through the DWI and Scottish Water.
Data linkage: assignment of fluoride level to
census small area units
Postcode distributions were used to link WSZs to each
SAU which was subsequently assigned a fluoride level. The
population centroid of each SAU was calculated in ESRI
ArcMap 9.331 to assign a weighted average for SAUs with
water supply from more than one WSZ. The Nondetects
and Data Analysis (NADA) add-on package for estimating
censored environmental data was used to compute values
for left-censored or missing data in R 281.32,33 Bone can-
cer cases were linked and aggregated for each 2001 census
SAU.
Statistical analysis
Negative binomial regression was implemented using
STATA version 12.34 The logarithm of the incidence rate
was modelled in two parts: (i) variation explained by
the data was expressed as a linear function of gender,
age-group and deprivation; (ii) unexplained variation was
modelled by a negative binomial distribution. The number
of cases observed in each SAU was the dependent variable
and the logarithm of the ‘at risk’ population was used as
the offset. Independent variables were the census-derived
SAU attributes that were allocated to the 2001 census
geography.22
The previously determined best-fitting models that ex-
plained bone cancer variation (the final models in the hier-
archical series for osteosarcoma and ES)13 were used as the
base models. In the present study, these models were ex-
tended to include fluoride level in drinking water by SAU.
For osteosarcoma, the base model included gender,
age-group, the interaction gender*age-group, the Town-
send score and the interaction Townsend*female. For ES,
the base model included age-group, gender, the interaction
age-group*gender, Scotland, East Midlands, population
density and non-car ownership. Fluoride, which had not
been analysed in the previous analysis, was then added to
these base models. The effect of fluoride level in drinking
water was tested in multivariable models whilst adjusting
for gender, age-group, population density and interactions.
The effect of fluoride was assessed, after adjustment for
these covariates, using likelihood ratio tests and the Akaike
Information Criterion (AIC).35 Relative risks (RRs) and
associated 90% confidence intervals (CIs) were
calculated.36
The mean fluoride level in drinking water was deter-
mined using monitoring data sampled between 2004 and
2006 and modelled as a continuous variable, under the as-
sumption that any association was linear. The effect of
fluoride level in drinking water was modelled with and
without adjustment for deprivation. To test the linearity
assumption, fluoride was also modelled as an ordinal vari-
able (dividing the distribution into fifths). To test for a pos-
sible threshold effect, the most fluoridated fifth of the
population was compared with less fluoridated fifths.
Also, areas with a level of at least 07 ppm, the lower limit
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of the range for optimum dental health benefit4 were com-
pared with less fluoridated areas.
Sensitivity analyses tested for effects of age-group. The
data were restricted to cases born within the following
non-overlapping cohorts: (i) before 1970; (ii) 1970–79;
and (iii) 1980 onwards. To test for constancy of fluoride
exposures in regions where levels may have fluctuated,
artefactually inflated levels (1 ppm) were analysed. Finally,
an analysis was carried out on the osteosarcoma data using
age-groups 0–9, 10-14,. . .45-49 years to assess whether the
three age-groups 0–14, 15–29 and 30–49 years were too
broad to detect increases limited to specific ages. This add-
itional analysis examined age-group interactions with
fluoride to test if the age-group 0–9 years was more
affected by fluoride than other age-groups. For all ana-
lyses, P-values were two-sided.
Results
The study analysed 2566 osteosarcoma cases (1493 males,
1073 females) and 1650 ES cases (988 males, 662 females)
aged 0–49 years. The numbers of cases by age-group and
gender are given in Table 1, with full descriptive data
given elsewhere.13 For osteosarcoma the overall age-
standardized rate (ASR) for all persons was 264 per mil-
lion persons per year (90% CI 255, 272), and 176 per
million persons per year (90% CI 168, 183) for ES. Most
analyses included an adjustment for deprivation.
After adjustment for gender, age-group, the interaction
gender*age-group, the Townsend score and the interaction
Townsend*female, no association was found between
osteosarcoma and fluoride levels in drinking water
(P¼ 0987). The RR for osteosarcoma for 1-ppm increase
in fluoride level was 1001 (90% CI 0871 to 1151). After
adjustment for age-group, gender, the interaction
age-group*gender, Scotland, East Midlands, population
density and non-car ownership, no association was found
between ES incidence and fluoride levels in drinking water
(P¼ 0503). The RR for ES for 1-ppm increase in fluoride
levels was 0929 (90% CI 0773 to 1115).
There was no effect without adjustment for deprivation.
Similarly, using ordinal measures there was no evidence of
any threshold effect. When testing cohorts born before
1970, 1970–79 and 1980 onwards, there was no differen-
tial effect of cohort on the association between bone cancer
and fluoride. An effect was not found when testing with
artefactually raised levels of fluoride (Tables 2–4), nor
when using narrower age-bands (0–9, 10–14. . .45–49
years). There was no evidence of an interaction between
age-group and fluoride.
Table 5 presents the mean fluoride level assigned to
each SAU in GB. The means range from 000 to 126 ppm;
48% of the SAUs had a fluoride level less than 010 ppm
and 80% had a level below 026 ppm. Approximately 70%
of the SAUs belonging to the upper fifth had fluoride levels
considered to provide the optimal dental decay prevention
benefit (070–120 ppm). This equated to approximately
14% of the total number of SAUs in GB having a fluoride
level within optimal limits. Five water companies in Eng-
land currently operate artificial fluoridation programmes
but not all their WSZs are artificially fluoridated (AF)
(Figure 1). The AF WSZs ranged from 004 to 108 ppm;
67% of the AF WSZs had a level within optimal limits.
Discussion
This ecological analysis used high-quality population-
based osteosarcoma and ES case data from 0–49-year-olds
diagnosed 1980–2005 in GB. The demographic profile of
the study population has previously been published.13
There was no evidence of an association between fluoride
in drinking water and osteosarcoma or ES. Thus, there was
no support for prior hypothesis (i) that geographical het-
erogeneity of osteosarcoma is modulated by differences in
fluoride levels. There was support for prior hypothesis (ii)
that geographical heterogeneity of ES is not modulated by
differences in fluoride levels.
This is the first study that has assessed fluoride levels in
drinking water across the whole of GB. Novel methodolo-
gies were developed within a GIS framework to enable
fluoride levels to be assigned to each SAU. Such an ap-
proach reduced the potential of misclassification of expos-
ure data when compared with previous studies that took
simpler approaches.37–39
The monitoring data suggested that levels in some AF
areas were much lower than 1 ppm. Indeed, 33% of AF
WSZs were below 07 ppm, the lower limit of the optimum
range for dental health benefit.4 It is noteworthy that this
corresponded to only 14% of all SAUs in GB having a
fluoride level that may confer a dental health benefit, and
Table 1. Number of cases of osteosarcoma and Ewing sar-
coma by age-group and gender
Age-group
(years)
Number of
osteosarcoma
cases
Number of
Ewing sarcoma
cases
Males Females Total Males Females Total
0-14 406 411 817 356 303 659
15-29 821 494 1315 516 284 800
30-49 266 168 434 116 75 191
0-49 1493 1073 2566 988 662 1650
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61% of AF SAUs had such a level. This suggests that 35%
of populations residing in AF areas were being supplied
with AF water dosed below the optimal level.
The relationship between fluoride and osteosarcoma
risk has been examined in a small number of animal40,41
and human studies37–39,41–48 with conflicting results. Dis-
agreement could be linked to fundamental differences in
study design; some studies were laboratory-based,40,41
some ecological,37,38,43–45 others were case-control.46–48
Moreover, investigations to date had several methodo-
logical limitations. These included limited statistical
power,37,46–48 the potential of selection bias in choice of
cases47,48 and controls48 or method of exposure categor-
ization leading to misclassification.
In a recent case-control study, Bassin and colleagues
analysed 103 cases (60 males, 43 females) aged under
20 years and found increased osteosarcoma risk with
fluoride in drinking water for males only, with a peak in
the age-group 6–8 years.47 However, the number of cases
within this age-group would have been extremely
small.49,50 A further limitation acknowledged by the
authors was potential selection bias because of differences
in case and control referral patterns to participating
hospitals.47
Table 2. Description of models used in the sensitivity analyses that tested the assumption that: (a) a continuous scale is an
appropriate level of measurement for quantity of fluoride in drinking water; (b) there was no change in the effect of fluoride by
cohort; and (c) fluoride levels in drinking water are constant over the study period
Model Test Factora,b
1
(a)
Fluoride level in drinking water as a continuous variable with adjustment for deprivation
2 Fluoride level in drinking water as a continuous variable without adjustment for deprivation
3 Fluoride level in drinking water as a discrete variable (quintiles) with adjustment for deprivation and comparison of
quintile 1 with quintile 2, 3, 4 and 5
4 Fluoride level in drinking water as a binary variable based on the highest (5th) quintile with adjustment for deprivation
5 Fluoride level in drinking water higher than 07 ppm are compared to levels that are less than 07 ppm (where fluoride level
as binary based on 07 ppm threshold) with adjustment for deprivation
6 Fluoride level in drinking water as a discrete variable (quintiles) without adjustment for deprivation and comparison of
quintile 1 with quintile 2, 3, 4 and 5
7 Fluoride level in drinking water as a binary variable based on the highest (5th) quintile without adjustment for deprivation
8 Fluoride levels in drinking water higher than 07 ppm are compared with levels that are less than 07 ppm (where fluoride
level as binary is based on 07 ppm threshold) without adjustment for deprivation
9
(b)
Fluoride level in drinking water (where cohort is restricted to include cases born before 1970)
10 Fluoride level in drinking water (where cohort is restricted to include cases born 1970 to 1979)
11 Fluoride level in drinking water (where cohort is restricted to include cases born 1980 or later)
12
(c)
Fluoride level in drinking water (where 10% of AF SAUs assigned a fluoride level of 1 ppm)
13 Fluoride level in drinking water (where 20% of AF SAUs assigned a fluoride level of 1 ppm)
14 Fluoride level in drinking water (where 30% of AF SAUs assigned a fluoride level of 1 ppm)
15 Fluoride level in drinking water (where 40% of AF SAUs assigned a fluoride level of 1 ppm)
16 Fluoride level in drinking water (where 100% of AF SAUs assigned a fluoride level of 1 ppm)
17 Fluoride level in drinking water (where pilot areas Watford, Kilmarnock & all Anglesey assigned a fluoride level of 1 ppm)
18 Fluoride level in drinking water (where pilot areas Watford, Kilmarnock & wards in north Anglesey assigned a fluoride
level of 1 ppm)
19 Fluoride level in drinking water (where pilot areas Watford, Kilmarnock & wards in south Anglesey assigned a fluoride
level of 1 ppm)
20 Fluoride level in drinking water (where pilot areas Watford, Kilmarnock & wards in east Anglesey assigned a fluoride level
of 1 ppm)
21 Fluoride level in drinking water (where pilot areas Watford, Kilmarnock & wards in west Anglesey assigned a fluoride level
of 1 ppm)
22 Fluoride level in drinking water (excluding all AF SAUs including those in Three Valleys)
23 Artificial fluoridation as a binary variable with adjustment for deprivation
aThe best fitting model for osteosarcoma is age-group, gender, gender*age-group, Townsend & Townsend*female.13
bThe best fitting model for Ewing sarcoma is age-group, gender, age-group*gender, Scotland, East Midlands, population density and non-car ownership.13
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Another case-control study using the same dataset
found no association, but again methods used introduced
limitations. There were 109 cases aged under 30 years, but
only 21 controls in this age range (median age for male
controls¼413 years; male cases¼ 170).48 It is also
possible that the use of other newly diagnosed malignant
bone tumours as the controls masked any differences if risk
also increased in those tumours.21 Furthermore, although
the overall results contradict those from Bassin’s study,51
the use of total accumulated fluoride dose rather than a
Table 3. Examination of the effect of fluoride level in drinking water on osteosarcoma incidence: comparison of fluoride models
and test results
Model dfb deviance AICc Difference in: Coefficient (with 90%
confidence interval)
Relative risk (with 90%
confidence interval)
Likelihood
ratio:
Numbera Comparison df deviance P-value
1 d 175665 179409 247548 1 0000 0001 (0138,0141) 1.001 (0.871,1.151) 0987
2 e 175667 179763 247862 1 0006 0006 (0145,0133) 0994 (0865,1142) 0940
3f d 175662 179365 247564 4 4368
(a) 0122 (0227,0016) (a) 0885 (0797,0984)
0359
(b) 0097 (0202,0009) (b) 0908 (0817,1009)
(c) 0056 (0160,0048) (c) 0946 (0853,1049)
(d) 0042 (0146,0061) (d) 0958 (0864,1063)
4 d 175665 179406 247545 1 0273 0026 (0056,0108) 1026 (0946,1114) 0602
5 d 175665 179408 247547 1 0114 0024 (0140,0093) 0976 (0869,1097) 0736
6f e 175664 179733 247891 4 3051
(a) 0102 (0207,0004) (a) 0903 (0813,1004)
0549
(b) 0038 (0142,0067) (b) 0963 (0867,1069)
(c) 0058 (0161,0046) (c) 0944 (0851,1047)
(d) 0016 (0119,0088) (d) 0984 (0888,1092)
7 e 175667 179759 247858 1 0440 0033 (0049,0115) 1034 (0952,1122) 0507
8 e 175667 179759 247858 1 0367 0043 (0159,0074) 0958 (0853,1076) 0545
9 g 175667 86698 114627 1 3425 0193 (0421,0036) 0825 (0656,1036) 0064
10 h 175665 65873 86060 1 0965 0148 (0097,0393) 1160 (0908,1482) 0326
11 i 117108 64391 86039 1 1656 0197 (0051,0445) 1218 (0951,1560) 0198
12 d 175665 179409 247547 1 0024 0013 (0150,0124) 0987 (0860,1132) 0876
13 d 175665 179408 247547 1 0066 0021 (0158,0115) 0979 (0854,1122) 0798
14 d 175665 179409 247548 1 0010 0008 (0141,0125) 0992 (0868,1133) 0921
15 d 175665 179409 247547 1 0021 0011 (0118,0141) 1011 (0889,1151) 0885
16 d 175665 179408 247547 1 0030 0013 (0106,0131) 1013 (0899,1140) 0862
17 d 175665 179409 247548 1 0006 0006 (0131,0143) 1006 (0877,1154) 0941
18 d 175665 179409 247547 1 0017 0011 (0126,0148) 1011 (0881,1160) 0896
19 d 175665 179409 247548 1 0005 0006 (0143,0132) 0994 (0866,1141) 0947
20 d 175665 179409 247548 1 0002 0004 (0134,0141) 1004 (0875,1152) 0963
21 d 175665 179409 247548 1 0000 0001 (0136,0139) 1001 (0873,1149) 0986
22 j 148137 149049 205272 1 1090 0156 (0086,0397) 1168 (0917,1488) 0297
23
g 175667 86698 114008 1 3425 0189 (0361,0017) 0828 (0697,0983) 0064
h 175665 65881 86068 1 0160 0045 (0139,0229) 1046 (0870,1257) 0689
i 117108 64375 86039 1 3216 0197 (0020,0373) 1218 (1021,1452) 0073
aPlease see Table 2a–c for model description.
bDegree of freedom.
cAkaike Information Criterion
dCompared with the non-fluoride model that contained age-group, gender, gender*age-group, Townsend & Townsend*female—cohort includes all cases in
GB for the whole of the study period.
eCompared with the non-fluoride model that contained age-group, gender, gender*age-group—cohort includes all cases in GB for the whole of the study
period.
fCoefficients and relative risks are reported for quintiles (a) 2, (b) 3, (c) 4 and (d) 5.
gCompared with the non-fluoride model that contained age-group, gender, unemployment—cohort is restricted to include cases born before 1970.
hCompared with the non-fluoride model that contained age-group, gender, gender*age-group, non-home ownership, non-home ownership *age-group—cohort
is restricted to include cases born between 1970 and 1979.
iCompared with the non-fluoride model that contained age-group, gender, gender*age-group, unemployment, unemployment*age-group—cohort is restricted
to include cases born 1980 or later.
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specific time in the life course prevents any direct compari-
sons being made.
A study did find a link between mean fluoride levels in
blood serum and increased osteosarcoma risk, but finding
this association does not infer causality.52 Mean fluoride
levels in cases with other bone-forming tumours were sig-
nificantly higher when compared with the control group
consisting of patients with musculo-skeletal pain only.
Table 4. Examination of the effect of fluoride level in drinking water on Ewing sarcoma incidence: comparison of fluoride mod-
els and test results
Model dfb deviance AICh Difference in: Coefficient (with 90%
confidence interval)
Relative risk (with 90%
confidence interval)
Likelihood
ratio:
Numbera Comparison df deviance P-value
1 d 175663 128748 173016 1 0448 0074 (0257,0109) 0929 (0773,1115) 0503
2 e 175664 128830 173078 1 0617 0086 (0269,0096) 0917 (0764,1101) 0432
3f d 175660 128696 173024 4 5630
(a) 0071 (0068,0211) (a) 1074 (0934,1235)
0229
(b) 0120 (0268,0027) (b) 0887 (0765,1028)
(c) 0019 (0174,0136) (c) 0981 (0840,1146)
(d) 0002 (0150,0146) (d) 0998 (0861,1157)
4 d 175663 128752 173020 1 0039 0013 (0094,0120) 1013 (0910,1128) 0843
5 d 175663 128749 173017 1 0351 0053 (0202,0095) 0948 (0817,1100) 0554
6f e 175661 128802 173110 4 3416
(a) 0069 (0071,0209) (a) 1071 (0931,1233)
0491
(b) 0076 (0222,0070) (b) 0927 (0801,1073)
(c) 0028 (0126,0182) (c) 1028 (0881,1199)
(d) 0011 (0137,0159) (d) 1011 (0872,1173)
7 e 175664 128836 173084 1 0002 0003 (0104,0110) 1003 (0901,1116) 0967
8 e 175664 128828 173076 1 0761 0078 (0225,0070) 0925 (0798,1073) 0383
9 g 175666 51381 65437 1 0679 0152 (0460,0156) 0859 (0631,1168) 0410
10 h 175665 52883 67974 1 0164 0072 (0366,0222) 0930 (0693,1249) 0685
11 i 117108 51270 67076 1 <0001 0022 (0293,0337) 1023 (0746,1401) 0996
12 d 175663 128747 173015 1 0564 0082 (0262,0098) 0921 (0769,1103) 0453
13 d 175663 128746 173014 1 0586 0083 (0261,0096) 0921 (0770,1101) 0444
14 d 175663 128747 173012 1 0807 0095 (0271,0080) 0909 (0763,1084) 0369
15 d 175663 128747 173014 1 0640 0083 (0253,0088) 0921 (0776,1092) 0424
16 d 175663 128745 173012 1 0780 0083 (0240,0073) 0920 (0787,1076) 0377
17 d 175663 128748 173016 1 0396 0068 (0248,0111) 0934 (0780,1118) 0529
18 d 175663 128747 173015 1 0513 0078 (0259,0103) 0925 (0772,1108) 0474
19 d 175663 128748 173016 1 0420 0071 (0251,0110) 0932 (0778,1116) 0517
20 d 175663 128747 173015 1 0520 0079 (0260,0102) 0924 (0771,1108) 0471
21 d 175663 128748 173016 1 0413 0070 (0251,0110) 0932 (0778,1117) 0520
22 j 148135 107981 144749 1 0037 0039 (0294,0372) 1040 (0745,1451) 0847
23
g 175666 51371 65427 1 1627 0178 (0412,0057) 0837 (0662,1058) 0202
h 175665 52885 67956 1 0010 0013 (0228,0202) 0987 (0796,1223) 0919
i 117108 51270 67076 1 <0001 0001 (0229,0227) 0999 (0796,1255) 0996
aPlease see Table 2a–c for model description.
bDegree of freedom.
cAkaike Information Criterion.
dCompared with the model that contains age-group, gender, age-group *gender, Scotland, East Midlands, population density and non-car ownership—cohort
includes all cases for whole of study period.
eCompared with the model that contains age-group, gender, age-group *gender, Scotland, East Midlands, population density—cohort includes all cases for
whole of study period.
fCoefficients and relative risks are reported for quintiles (a) 2, (b) 3, (c) 4 and (d) 5.
gCompared with the non-fluoride model that contained age-group, gender, population density, unemployment—cohort is restricted to include cases born before
1970.
hCompared with the non-fluoride model that contained age-group, gender, age-group *gender, population density, unemployment—cohort is restricted to in-
clude cases born between 1970 and 1979.
iCompared with the non-fluoride model that contained age-group, gender, age-group *gender, Scotland, unemployment—cohort is restricted to include cases
born 1980 or later.
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Although the mean fluoride level was only approximately
50% of the osteosarcoma group, it highlights caution
when selecting controls.
Two ecological studies from the USA and from Ireland
concluded water fluoridation status had no influence on
osteosarcoma incidence rates.38,39 However, both studies
had shortcomings due to the methods of exposure data cat-
egorization. The US study categorized states according to
high and low community water fluoridation.37 Other stud-
ies merely compared bone cancer incidence in areas with
and without artificial fluoridation programmes.38,39 The
bioavailability and chemistry have been assessed, with no
difference being found between naturally occurring and
artificial fluoride.53 Similarly, another experimental dou-
ble-blind cross-over trial reported no difference in bioavail-
ability although this finding needed to be treated
cautiously due to small case numbers.54
The present study had some limitations. It is a small
area study and assumed that the characteristics of each in-
dividual within a designated area were represented by the
aggregate statistics for that area. However, although these
studies are susceptible to the ecological fallacy,55 ecolo-
gical analyses are suited to initial investigation of causal
hypotheses.56 Artificial fluoridation programmes are ne-
cessarily ecological but are considered an effective method
of providing populations with the dental health benefit of
fluoride.22,23
Lack of availability and inconsistency of individual
sampling data across the whole of GB during the study
period (only 2004–06 data were used) meant an assump-
tion was made of no change in fluoride levels within the
study time-frame. However, this assumption was substan-
tiated through sensitivity analyses (Tables 2-4). The fluctu-
ations in fluoride levels over time were assessed. Fluoride
levels in England fluctuated plus or minus 10%. Since
source data for Scotland were limited to 2004–06 and
more variation was found in Wales, the main analysis was
repeated using data for England only. It found the best-
fitting models had the same predictors as the whole of GB.
It is well established that fluoride concentrations in
bone increase with age.57 To determine whether age or
time of putative exposure had influenced the findings, the
analyses were repeated using non-overlapping birth co-
horts (before 1970, 1970–79 and 1980 onwards). For all
three cohorts, there was no evidence of any association
with risk (Tables 2–4). This confirmed that making an as-
sumption of stable fluoride concentrations over time was
reasonable.
Finding no association might be because of attenuation
due to exposure measurement error, arising through the
imprecision in allocating fluoride levels to specific areas
during specific periods. For example, the WSZ boundaries
have changed over time but it was not possible to represent
these changes, as digital boundary data have only been
archived since 2004. Lack of data availability also made it
impossible to take any local changes within artificial fluor-
idation supply areas into account.
SAU of residence at time of diagnosis may not represent
the true lifetime or shorter period of fluoride exposure for
each case. Other sources of fluoride are not taken into con-
sideration. In the 1950s when the first pilot studies were
carried out in GB, there was much less availability from
other sources. Fluoride started to be added to toothpaste in
the 1970s and by 1978 approximately 96% of all tooth-
pastes were fluoridated. Nevertheless, it is believed that
drinking water is still the primary source of fluoride in GB,
particularly in areas with fluoride levels of 1 ppm and
over.4
In conclusion, this small area analysis used high-quality
population-based osteosarcoma and ES case data. Novel
GIS methodologies were developed to enable fluoride level
in drinking water to be assigned to each SAU in GB. No as-
sociation was found between fluoride level and osteosar-
coma or ES before and after adjustment for deprivation.
The findings from this study provide no evidence that
higher levels of fluoride (whether natural or artificial) in
drinking water in GB lead to greater risk of osteosarcoma
or ES. Ecological design was appropriate for this initial in-
vestigation but also introduced limitations. Further re-
search, such as large case-control studies that incorporate
the GIS methodologies developed during this study, is
recommended.
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Table 5. The upper and lower limits of each fluoride category
(the average level of fluoride assigned to each census small
area unit (SAU) in parts per million (ppm) and then the SAU
population distribution ranked and divided into fifths)
Fluoride category
(SAU population distribution
divided into fifths)
Average level of fluoride assigned
to each census SAU (ppm)
(upper and lower limits of
fluoride category)
1 (lower fifth) 0000000 – 0048969
2 0048970 – 0078770
3 0078771 – 0138820
4 0138821 – 0254040
5 (upper fifth) 0254041 – 1268000
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